Literature DB >> 18923538

X chromosome inactivation: heterogeneity of heterochromatin.

Sharan K Sidhu1, Jakub Minks, Samuel C Chang, Allison M Cotton, Carolyn J Brown.   

Abstract

The silent X chromosome in mammalian females is a classic example of facultative heterochromatin, the term highlighting the compacted and inactive nature of the chromosome. However, it is now clear that the heterochromatin of the inactive X is not homogeneous--as indeed, not all genes on the inactive X are silenced. We summarize known features and events of X inactivation in different mouse and human model systems, and highlight the heterogeneity of chromatin along the inactive X. Characterizing this heterogeneity is likely to provide insight into the cis-acting sequences involved in X chromosome inactivation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18923538     DOI: 10.1139/o08-100

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  4 in total

Review 1.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  The impact of intragenic CpG content on gene expression.

Authors:  Asli Petra Bauer; Doris Leikam; Simone Krinner; Frank Notka; Christine Ludwig; Gernot Längst; Ralf Wagner
Journal:  Nucleic Acids Res       Date:  2010-03-04       Impact factor: 16.971

Review 3.  Environmental and epigenetic effects upon preimplantation embryo metabolism and development.

Authors:  Rebecca J Chason; John Csokmay; James H Segars; Alan H DeCherney; D Randall Armant
Journal:  Trends Endocrinol Metab       Date:  2011-07-07       Impact factor: 12.015

4.  46,X,del(X)(q13) Turner's syndrome women with systemic lupus erythematosus in a pedigree multiplex for SLE.

Authors:  C M Cooney; G R Bruner; T Aberle; B Namjou-Khales; L K Myers; L Feo; S Li; A D'Souza; A Ramirez; J B Harley; R H Scofield
Journal:  Genes Immun       Date:  2009-05-21       Impact factor: 2.676

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.